Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
How do you weigh upfront nodal burden when deciding to omit PMRT in a patient with cN1, ypN0 disease after neoadjuvant chemo, mastectomy and ALND?
For example, if the patient had several abnormal nodes radiographically vs 1-2.
Answer from: Radiation Oncologist at Community Practice
Pre-chemo imaging if it shows 4 or more abnormal nodes (N2) then would offer RNI irrespective of response.
Sign In
or
Register
to read more
26565
Related Questions
Do you boost a breast cavity for a high Ki-67 index in the absence of other risk factors?
How do you assess and counsel women with chronic post-lumpectomy or mastectomy pain?
Have the 10-year results from UK FAST-Forward presented at ESTRO 2025 impacted your practice with regard to patient selection?
How does SUPREMO alter your recommendations for PMRT?
What are your top takeaways in Breast Cancer from ASCO 2025?
Is FAST-Forward/ultra-hypofractionation suitable for an early-stage breast patient after a lumpectomy with oncoplastic reduction?
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
Does your dosimetrist use skin flash for VMAT whole breast or RNI plans?
Would you recommend PMRT in a patient with a triple negative cT2N0, ypT2N0 metaplastic breast cancer s/p NAC, mastectomy, and SLNB?
Does a high genomic risk score impact your radiation fields for patients with breast cancer?